W.R. Berkley Corp’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

W.R. Berkley Corp’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-109,601	Closed	-$2.08M	–	144
2019 Q1	$2.08M	Buy	+109,601	New	+$1.78M	0.44%	58

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

W.R. Berkley Corp's OSIR Position: Q2 2019 in Review

W.R. Berkley Corp sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 109,601 shares — an estimated $2.08M sold.

W.R. Berkley Corp first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $2.08M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

W.R. Berkley Corp reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
W.R. Berkley Corp sold 109,601 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $2.08M.
W.R. Berkley Corp first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
W.R. Berkley Corp's Osiris Therapeutics, Inc. Common Stock position peaked at $2.08M in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on W.R. Berkley Corp's 13F filing for Q2 2019, filed 14 Aug 2019.